US Stock MarketDetailed Quotes

GDTC CytoMed Therapeutics

Watchlist
  • 2.260
  • -0.500-18.12%
Close Jan 13 16:00 ET
  • 2.350
  • +0.090+3.98%
Post 17:59 ET
26.08MMarket Cap-11.65P/E (TTM)

CytoMed Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Total revenue
0
0
0
0
Operating revenue
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
106.99%3.84M
7.43%1.86M
37.57%1.73M
1.26M
Selling and administrative expenses
223.37%1.28M
36.32%397.11K
47.87%291.32K
--197.01K
-Selling and marketing expense
--33.31K
--0
-59.87%2.48K
--6.18K
-General and administrative expense
214.98%1.25M
37.49%397.11K
51.36%288.84K
--190.83K
Research and development costs
4.40%1.59M
39.62%1.52M
5.06%1.09M
--1.04M
Depreciation amortization depletion
-6.88%104.05K
10.38%111.75K
16.86%101.23K
--86.63K
-Depreciation and amortization
-6.88%104.05K
10.38%111.75K
16.86%101.23K
--86.63K
Other taxes
-5.45%6.66K
72.63%7.05K
17.17%4.08K
--3.48K
Other operating expenses
571.33%858.3K
-175.58%-182.1K
449.36%240.93K
---68.96K
Operating profit
-106.99%-3.84M
-7.43%-1.86M
-37.57%-1.73M
-1.26M
Net non-operating interest income expense
290.48%234.44K
-7.65%-123.08K
-8.35%-114.33K
-105.52K
Non-operating interest income
13,525.13%285.72K
-37.76%2.1K
--3.37K
--0
Non-operating interest expense
-59.03%51.28K
6.35%125.18K
11.54%117.7K
--105.52K
Other net income (expense)
54.43%-524.11K
-449.29%-1.15M
63.51%-209.39K
-573.86K
Gain on sale of security
-1,391.77%-394.16K
-178.68%-26.42K
-2,089.61%-9.48K
---433
Earnings from equity interest
7.00%-31.2K
84.22%-33.55K
---212.58K
--0
Special income (charges)
--0
--280
--0
--0
-Gain on sale of property,plant,equipment
--0
--280
--0
--0
Other non- operating income (expenses)
90.94%-98.75K
-8,709.51%-1.09M
102.21%12.67K
---573.42K
Income before tax
-32.04%-4.13M
-52.53%-3.13M
-6.01%-2.05M
-1.94M
Income tax
-60.18%653
1.64K
0
0
Net income
-31.99%-4.13M
-52.61%-3.13M
-6.01%-2.05M
-1.94M
Net income continuous Operations
-31.99%-4.13M
-52.61%-3.13M
-6.01%-2.05M
---1.94M
Minority interest income
-12.76%-274
3.95%-243
-36.02%-253
-186
Net income attributable to the parent company
-31.99%-4.13M
-52.62%-3.13M
-6.00%-2.05M
-1.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-31.99%-4.13M
-52.62%-3.13M
-6.00%-2.05M
-1.94M
Basic earnings per share
-36.26%-0.39
-52.62%-0.2862
-6.00%-0.1875
-0.1769
Diluted earnings per share
-36.26%-0.39
-52.62%-0.2862
-6.00%-0.1875
-0.1769
Dividend per share
Currency Unit
SGD
SGD
SGD
SGD
Audit Opinions
Unqualified Opinion
Unqualified Opinion
--
--
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Total revenue 0000
Operating revenue --0--0--0--0
Cost of revenue
Gross profit
Operating expense 106.99%3.84M7.43%1.86M37.57%1.73M1.26M
Selling and administrative expenses 223.37%1.28M36.32%397.11K47.87%291.32K--197.01K
-Selling and marketing expense --33.31K--0-59.87%2.48K--6.18K
-General and administrative expense 214.98%1.25M37.49%397.11K51.36%288.84K--190.83K
Research and development costs 4.40%1.59M39.62%1.52M5.06%1.09M--1.04M
Depreciation amortization depletion -6.88%104.05K10.38%111.75K16.86%101.23K--86.63K
-Depreciation and amortization -6.88%104.05K10.38%111.75K16.86%101.23K--86.63K
Other taxes -5.45%6.66K72.63%7.05K17.17%4.08K--3.48K
Other operating expenses 571.33%858.3K-175.58%-182.1K449.36%240.93K---68.96K
Operating profit -106.99%-3.84M-7.43%-1.86M-37.57%-1.73M-1.26M
Net non-operating interest income expense 290.48%234.44K-7.65%-123.08K-8.35%-114.33K-105.52K
Non-operating interest income 13,525.13%285.72K-37.76%2.1K--3.37K--0
Non-operating interest expense -59.03%51.28K6.35%125.18K11.54%117.7K--105.52K
Other net income (expense) 54.43%-524.11K-449.29%-1.15M63.51%-209.39K-573.86K
Gain on sale of security -1,391.77%-394.16K-178.68%-26.42K-2,089.61%-9.48K---433
Earnings from equity interest 7.00%-31.2K84.22%-33.55K---212.58K--0
Special income (charges) --0--280--0--0
-Gain on sale of property,plant,equipment --0--280--0--0
Other non- operating income (expenses) 90.94%-98.75K-8,709.51%-1.09M102.21%12.67K---573.42K
Income before tax -32.04%-4.13M-52.53%-3.13M-6.01%-2.05M-1.94M
Income tax -60.18%6531.64K00
Net income -31.99%-4.13M-52.61%-3.13M-6.01%-2.05M-1.94M
Net income continuous Operations -31.99%-4.13M-52.61%-3.13M-6.01%-2.05M---1.94M
Minority interest income -12.76%-2743.95%-243-36.02%-253-186
Net income attributable to the parent company -31.99%-4.13M-52.62%-3.13M-6.00%-2.05M-1.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -31.99%-4.13M-52.62%-3.13M-6.00%-2.05M-1.94M
Basic earnings per share -36.26%-0.39-52.62%-0.2862-6.00%-0.1875-0.1769
Diluted earnings per share -36.26%-0.39-52.62%-0.2862-6.00%-0.1875-0.1769
Dividend per share
Currency Unit SGDSGDSGDSGD
Audit Opinions Unqualified OpinionUnqualified Opinion----
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+2.17%
Advanced Micro Devices
AMD
+1.10%
Adobe
ADBE
+0.64%
Broadcom
AVGO
+0.44%
Salesforce
CRM
+0.38%

Unlock the Full List

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-3.56%